iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · IEX Real-Time Price · USD
15.73
-0.57 (-3.50%)
At close: Jul 19, 2024, 4:00 PM
15.69
-0.04 (-0.25%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
iTeos Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for iTeos Therapeutics stock have an average target of 33.75, with a low estimate of 27 and a high estimate of 46. The average target predicts an increase of 114.56% from the current stock price of 15.73.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2024.
Analyst Ratings
The average analyst rating for ITOS stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $44 → $46 | Strong Buy | Maintains | $44 → $46 | +192.43% | May 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $27 | Buy | Maintains | $29 → $27 | +71.65% | Mar 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +179.72% | Mar 7, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $29 | Buy | Maintains | $32 → $29 | +84.36% | Nov 13, 2023 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +109.79% | Oct 18, 2023 |
Financial Forecast
Revenue This Year
3.32M
from 12.60M
Decreased by -73.68%
Revenue Next Year
9.44M
from 3.32M
Increased by 184.62%
EPS This Year
-4.32
from -3.15
EPS Next Year
-5.21
from -4.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.7M | 38.9M | 99.6M | 288.1M | 465.9M |
| Avg | 3.3M | 9.4M | 41.0M | 171.6M | 348.1M |
| Low | n/a | n/a | n/a | 16.6M | 180.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.4% | 1,071.9% | 955.5% | 603.1% | 171.5% |
| Avg | -73.7% | 184.6% | 334.3% | 318.8% | 102.9% |
| Low | - | - | - | -59.4% | 5.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.83 | -3.34 | -3.81 | 0.17 | 2.79 |
| Avg | -4.32 | -5.21 | -5.18 | -2.63 | 0.21 |
| Low | -4.61 | -6.22 | -7.03 | -5.21 | -2.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.